Cancer and Leukemia Group B
Cancer and Leukemia Group B
批准号:
6892330
负责人:
Thomas C. Shea
金额:
$12.78万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-06-01 至 2006-03-31
关键词:
AIDS related neoplasm /canceragingantineoplasticsbone marrow transplantationbreast neoplasmscancer preventioncancer registry /resourcecarmustinechemopreventioncis platinum compoundclinical researchclinical trialscombination cancer therapycombination chemotherapycooperative studycyclophosphamidedoxorubicindrug resistancefinasteridefluorouracilgastrointestinal neoplasmshealth care cost /financinghormone therapyhuman genetic material taghuman subjecthuman therapy evaluationinterleukin 2leucovorinleukemialymphomamelanomaneoplasm /cancer chemotherapyneoplasm /cancer diagnosisneoplasm /cancer epidemiologyneoplasm /cancer geneticsneoplasm /cancer immunotherapyneoplasm /cancer radiation therapyneoplasm /cancer surgeryneoplasm /cancer vaccineoncology nursingpaclitaxelpathologyprostate neoplasmspsychologyquality of liferespiratory neoplasmtamoxifentissue resource /registryweight loss
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application represents the second competitive renewal of the CALGB institutional grant submission from the University of North Carolina at Chapel Hill (UNC-CH) and its affiliates. UNC-CH has been a member of CALGB since 1986. Our accrual has been maintained at approximately 40 treatment cases (including 6-10 minority accruals/year) plus companion studies. We also maintain an affiliate network responsible for another 60-90 accruals/year while maintaining excellent data quality control. Moreover, our institution now has broad leadership participation in the Group in Breast, Cancer Prevention and Control, GI, Lymphoma, Molecular Pathology, Radiation Oncology, and is the research base for a UNC based Minority Initiative Program and a VCU based Minority CCOP. Moreover, our leadership efforts in the Group have also continued to expand. We now enjoy the distinction of having one committee chair, five committee vice-chairs, seven committee or working group core or liaison members, eight modality committee members, one Executive Committee member, two members of the Board of Directors, five administrative committee members and seven protocol principal investigators. Members from UNC and its affiliates have held 56 positions on various scientific, administrative, and leadership committees of CALGB during the past 5 years. Additional faculty at UNC-CH will expand our commitment and Group leadership in the Breast, Surgery, GU, GI, Lymphoma and PET committees (F. Detterbeck, M. Graham, C. Sartor, L. Carey, J. Mohler, R. Pruthi, B. O'Neil, R. Orlowski, P. Watkins, and C. Dees). We therefore believe that this application reflects the growing and crucial contribution that UNC-CH investigators provide to the Group in leadership, science and service as well as our continued efforts to increase accrual through affiliate members while maintaining rigorous control of quality data submission. We respectfully submit that this application demonstrates both the current value of this institution to the Group and the contributions that: the membership of UNC-CH and its affiliates will continue to provide CALGB over the next five years.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--PROTOCOL REVIEW AND MONITORING SYSTEM
-
批准号:7100785
-
项目类别:
-
资助金额:$8.15万
-
财政年份:2004
-
负责人:Thomas C. Shea
-
依托单位:
FILGRASTIM ALONE OR IN COMBINATION W/ R METHUSCF IN BREAST CANCER
-
批准号:6566079
-
项目类别:
-
资助金额:$19.07万
-
财政年份:2001
-
负责人:Thomas C. Shea
-
依托单位:
PHARMACODYNAMIC MODELING OF ORAL ETOPOSIDE IN RELAPSED NON HODGKINS
-
批准号:6566059
-
项目类别:
-
资助金额:$19.07万
-
财政年份:2001
-
负责人:Thomas C. Shea
-
依托单位:
PHARMACODYNAMIC MODELING OF ORAL ETOPOSIDE IN RELAPSED NON HODGKINS
-
批准号:6423230
-
项目类别:
-
资助金额:$29.46万
-
财政年份:2000
-
负责人:Thomas C. Shea
-
依托单位:
PHARMACODYNAMIC MODELING OF ORAL ETOPOSIDE IN RELAPSED NON HODGKINS
-
批准号:6504207
-
项目类别:
-
资助金额:$19.07万
-
财政年份:2000
-
负责人:Thomas C. Shea
-
依托单位:
FILGRASTIM ALONE OR IN COMBINATION W/ R METHUSCF IN BREAST CANCER
-
批准号:6504227
-
项目类别:
-
资助金额:$19.07万
-
财政年份:2000
-
负责人:Thomas C. Shea
-
依托单位:
FILGRASTIM ALONE OR IN COMBINATION W/ R METHUSCF IN BREAST CANCER
-
批准号:6423250
-
项目类别:
-
资助金额:$29.46万
-
财政年份:2000
-
负责人:Thomas C. Shea
-
依托单位:
HIGH DOSE CARBOPLATIN AND PACLITAXEL WITH G-CSF IN NON-SMALL CELL LUNG CANCER
-
批准号:6113933
-
项目类别:
-
资助金额:$1.58万
-
财政年份:1998
-
负责人:Thomas C. Shea
-
依托单位:
PHARMACODYNAMIC MODELING OF ORAL ETOPOSIDE IN RELAPSED NON HODGKINS
-
批准号:6263850
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:Thomas C. Shea
-
依托单位:
FILGRASTIM ALONE OR IN COMBINATION W/ R METHUSCF IN BREAST CANCER
-
批准号:6263870
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:Thomas C. Shea
-
依托单位:
PHARMACODYNAMIC MODELING OF ORAL ETOPOSIDE IN RELAPSED NON HODGKINS
-
批准号:6297218
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:Thomas C. Shea
-
依托单位:
FILGRASTIM ALONE OR IN COMBINATION W/ R METHUSCF IN BREAST CANCER
-
批准号:6297238
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:Thomas C. Shea
-
依托单位:
BLOOD PROGENITOR CELL MOBILIZATION BY R-METHUSCF & R-METHUG-CSF IN BREAST CANCER
-
批准号:6244976
-
项目类别:
-
资助金额:$1.34万
-
财政年份:1997
-
负责人:Thomas C. Shea
-
依托单位:
HIGH DOSE CARBOPLATIN AND PACLITAXEL WITH G-CSF IN NON-SMALL CELL LUNG CANCER
-
批准号:6275168
-
项目类别:
-
资助金额:$1.58万
-
财政年份:1997
-
负责人:Thomas C. Shea
-
依托单位:
PERIPHERAL BLOOD STEM CELLS AND HIGH DOSE CHEMOTHERAPY
-
批准号:3509642
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1992
-
负责人:Thomas C. Shea
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:6172196
-
项目类别:
-
资助金额:$11.5万
-
财政年份:1991
-
负责人:Thomas C. Shea
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:2599516
-
项目类别:
-
资助金额:$19.36万
-
财政年份:1991
-
负责人:Thomas C. Shea
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:2894766
-
项目类别:
-
资助金额:$11.96万
-
财政年份:1991
-
负责人:Thomas C. Shea
-
依托单位:
Cancer and Leukemia Group B
-
批准号:8449714
-
项目类别:
-
资助金额:$14.5万
-
财政年份:1991
-
负责人:Thomas C. Shea
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:2092635
-
项目类别:
-
资助金额:$17.02万
-
财政年份:1991
-
负责人:Thomas C. Shea
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
-
批准号:82371603
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈晓
-
依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
-
批准号:82370743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姜娜
-
依托单位:
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
-
批准号:82371585
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:周鲁明
-
依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
-
批准号:82370774
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮渊
-
依托单位:
LMNA基因R527C纯合突变儿童早老症干细胞功能异常及分子机理研究
-
批准号:32100603
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周焱
-
依托单位:
SIRT2在灵长类心肌衰老进程中的作用及其机制研究
-
批准号:32000510
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:范艳玲
-
依托单位:
NRF2/MFN2/ERS信号异常促进ADSCs衰老和肥大型肥胖皮下脂肪组织胰岛素抵抗的机制研究
-
批准号:32000511
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:方佳
-
依托单位:
隐性遗传方式儿童早老症患者SASP-like炎症反应病理特征和分子机制研究
-
批准号:32060157
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:舒伟
-
依托单位:
c-Fos在皮肤上皮干细胞衰老中的作用研究
-
批准号:32070730
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:张亮
-
依托单位:
SETD8介导H4K20单甲基化修饰对MSCs抗衰老的作用机制
-
批准号:32060156
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:刘鹏霞
-
依托单位: